Kabra Drugs Ltd — Insider Trading, 30-12-2025: Insider Trading / SAST

Kabra Drugs Limited has announced the closure of its trading window for designated persons and their immediate relatives, effective from January 1st. This window will remain closed until 48 hours after the declaration of the financial results for the quarter and nine months ended December 31st. This is a standard measure to prevent insider trading and ensure fair market practices before the release of key financial information. The company will separately announce the date for its board meeting to consider these upcoming results.